Wanbury Limited’s Board of Directors has approved key financial decisions, including raising ₹175 crore through non-convertible debentures (NCDs) and granting 2,00,000 stock options under its ESOP 2016 scheme.
The shares of Wanbury Limited were trading at ₹222.38 down by ₹2.31 or 1.03 per cent on the NSE today at 11.55 am.
- Also read: PLI scheme: PMO holds back approval for new sectors, tenure extensions
The company will issue secured, unrated, unlisted and redeemable NCDs on a private placement basis to Emerging India Credit Opportunities Fund II. The tenure for the debentures is set at 60 months, with a fixed coupon rate, and repayment due at the end of the term. The funds will be used for refinancing high-cost debt, capital expenditure and working capital needs.
Additionally, the board granted 2,00,000 stock options to eligible employees, vesting over three years in a mix of loyalty and performance-based allocations. The exercise price is ₹10 per share, with a two-year window for exercising vested options.
- Also read: India’s CDMO market set to double by 2028 amid Asia’s healthcare boom
Wanbury also reported its unaudited financial results for Q3 and the nine-month period ending December 31, 2024. While revenue for the quarter stood at ₹13,345.18 lakh, the net profit was ₹121.77 lakh, reflecting a decline from the previous quarter’s ₹801.85 lakh due to a planned 30-day shutdown of its Tanuku facility for major upgrades.
The company remains optimistic about future growth, citing the successful clearance of an ANVISA inspection at its Tanuku plant.
